Dongjie Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dongjie Peng has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Shaojun Li
Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning 530021, China
4 shared publications - Feiyu Zhao
Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning 530021, China
2 shared publications - Huishuai Li
Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning 530021, China
2 shared publications - Junyan Li
Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, China
2 shared publications - Lin Zhao
Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, China
2 shared publications - Michael Aschner
Department of Molecular Pharmacology, Albert Einstein College of Medicine
2 shared publications
Latest Publications
- Open Access
Neonatal Disorders Across the Development Gradient: Inequality Divergence and Future Trajectories
Purpose: To characterise the global burden of neonatal disorders across the socio-demographic development gradient, with emphasis on temporal trends, absolute and relative inequality, attributable risks, and future trajectories. Methods: Using Global Burden of Disease 2021 data, we analysed age-standardised incidence, prevalence, mortality, and disability-adjusted life-year (DALY) rates across 204 countries and territories from 1990 to 2021. Temporal trends were quantified using estimated annual percentage change. Development-related inequality was assessed using the slope index of inequality and concentration index. Attributable burden was evaluated for low birth weight, short gestation, ambient particulate matter pollution, and household air pollution from solid fuels. UN IGME neonatal mortality estimates were used for external validation. Trends to 2050 were projected using ARIMA, ETS, and ARIMAX-SDI models. Results: In 2021, neonatal disorders remained disproportionately concentrated in low-SDI settings, particularly sub-Saharan Africa and South Asia. Mortality and DALY rates declined substantially from 1990 to 2021, whereas incidence and prevalence showed less favourable trends. Absolute inequality narrowed, but relative inequality widened, indicating that progress was not distributed proportionately across the development gradient. Preterm birth was the leading burden component, while low birth weight and short gestation were the dominant attributable risks. Projections suggested continued declines in mortality and DALY rates but increasing prevalence through 2050. Conclusion: Neonatal disorders remain a development-sensitive global health burden. Strategies should extend beyond mortality reduction to include prevention of prematurity and low birth weight, mitigation of context-specific environmental risks, and long-term care for morbidity among survivors.
Open AccessNeonatal Disorders Across the Development Gradient: Inequality Divergence and Future Trajectories
Purpose: To characterise the global burden of neonatal disorders across the socio-demographic development gradient, with emphasis on temporal trends, absolute and relative inequality, attributable risks, and future trajectories. Methods: Using Global Burden of Disease 2021 data, we analysed age-standardised incidence, prevalence, mortality, and disability-adjusted life-year (DALY) rates across 204 countries and territories from 1990 to 2021. Temporal trends were quantified using estimated annual percentage change. Development-related inequality was assessed using the slope index of inequality and concentration index. Attributable burden was evaluated for low birth weight, short gestation, ambient particulate matter pollution, and household air pollution from solid fuels. UN IGME neonatal mortality estimates were used for external validation. Trends to 2050 were projected using ARIMA, ETS, and ARIMAX-SDI models. Results: In 2021, neonatal disorders remained disproportionately concentrated in low-SDI settings, particularly sub-Saharan Africa and South Asia. Mortality and DALY rates declined substantially from 1990 to 2021, whereas incidence and prevalence showed less favourable trends. Absolute inequality narrowed, but relative inequality widened, indicating that progress was not distributed proportionately across the development gradient. Preterm birth was the leading burden component, while low birth weight and short gestation were the dominant attributable risks. Projections suggested continued declines in mortality and DALY rates but increasing prevalence through 2050. Conclusion: Neonatal disorders remain a development-sensitive global health burden. Strategies should extend beyond mortality reduction to include prevention of prematurity and low birth weight, mitigation of context-specific environmental risks, and long-term care for morbidity among survivors.
- Open Access
Prevalence of Aflatoxin B1 and Other Quality Indicators in Artisanal Peanut Oil from Small-Scale Workshops in Nanning, China
Objective: To characterize aflatoxin B1 (AFB1) contamination, oil-quality variation, workshop hygiene, and modeled dietary risk associated with artisanal peanut oil produced by small-scale workshops in Nanning, China. Methods: A cross-sectional study was conducted in 144 workshops across all 12 county-level administrative areas of Nanning, with one peanut-oil sample collected from each workshop. On-site hygiene practices were assessed using a structured 13-item instrument. AFB1 concentration, acid value, and peroxide value were measured using national standard methods. Regional differences were evaluated using non-parametric tests, and K-means clustering was applied to characterize multivariate quality profiles. Dietary exposure was assessed using estimated daily intake (EDI), margin of exposure (MOE), and modeled AFB1-attributable hepatocellular carcinoma (HCC) risk. Results: AFB1 was detected in 88.2% of samples, while 3.5% exceeded the Chinese maximum level of 20 μg/kg. Samples from counties had significantly higher AFB1 concentrations, acid values, and peroxide values than those from municipal districts (all p < 0.001). Compliance was relatively high for basic hygiene and spatial separation, whereas routine contaminant testing was reported by only 18% of workshops and aflatoxin-degradation equipment was available in 35%. The primary clustering analysis identified overall-low (81.2%), AFB1-dominant (9.7%), and rancidity-dominant (9.0%) profiles, whereas sensitivity analysis after log10 transformation favored a broader two-cluster structure. Estimated AFB1 intake was higher under the rural than the urban scenario (2.6436 vs. 0.6890 ng/kg bw/day), with corresponding MOE values of 151.31 and 580.55. Modeled HCC risk was also higher under the rural scenario and under the hepatitis B surface antigen-positive scenario. Conclusions: Artisanal peanut oil from small-scale workshops in Nanning showed frequent AFB1 detection, marked regional variation in multiple quality indicators, and limited implementation of contaminant-specific control practices. These findings support closer attention to routine AFB1 monitoring, storage management, and broader quality control, particularly in county settings.
Open AccessPrevalence of Aflatoxin B1 and Other Quality Indicators in Artisanal Peanut Oil from Small-Scale Workshops in Nanning, China
Objective: To characterize aflatoxin B1 (AFB1) contamination, oil-quality variation, workshop hygiene, and modeled dietary risk associated with artisanal peanut oil produced by small-scale workshops in Nanning, China. Methods: A cross-sectional study was conducted in 144 workshops across all 12 county-level administrative areas of Nanning, with one peanut-oil sample collected from each workshop. On-site hygiene practices were assessed using a structured 13-item instrument. AFB1 concentration, acid value, and peroxide value were measured using national standard methods. Regional differences were evaluated using non-parametric tests, and K-means clustering was applied to characterize multivariate quality profiles. Dietary exposure was assessed using estimated daily intake (EDI), margin of exposure (MOE), and modeled AFB1-attributable hepatocellular carcinoma (HCC) risk. Results: AFB1 was detected in 88.2% of samples, while 3.5% exceeded the Chinese maximum level of 20 μg/kg. Samples from counties had significantly higher AFB1 concentrations, acid values, and peroxide values than those from municipal districts (all p < 0.001). Compliance was relatively high for basic hygiene and spatial separation, whereas routine contaminant testing was reported by only 18% of workshops and aflatoxin-degradation equipment was available in 35%. The primary clustering analysis identified overall-low (81.2%), AFB1-dominant (9.7%), and rancidity-dominant (9.0%) profiles, whereas sensitivity analysis after log10 transformation favored a broader two-cluster structure. Estimated AFB1 intake was higher under the rural than the urban scenario (2.6436 vs. 0.6890 ng/kg bw/day), with corresponding MOE values of 151.31 and 580.55. Modeled HCC risk was also higher under the rural scenario and under the hepatitis B surface antigen-positive scenario. Conclusions: Artisanal peanut oil from small-scale workshops in Nanning showed frequent AFB1 detection, marked regional variation in multiple quality indicators, and limited implementation of contaminant-specific control practices. These findings support closer attention to routine AFB1 monitoring, storage management, and broader quality control, particularly in county settings.
- 14 January 2021
- Published by Springer Nature in Biological Trace Element Research
- Vol. 199 (12) , 4688-4699
Sodium P-aminosalicylic Acid Attenuates Manganese-Induced Neuroinflammation in BV2 Microglia by Modulating NF-κB Pathway
Exposure to high levels of manganese (Mn) leads to brain Mn accumulation, and a disease referred to as manganism. Activation of microglia plays an important role in Mn-induced neuroinflammation. Sodium p-aminosalicylic acid (PAS-Na) is a non-steroidal anti-inflammatory drug that inhibits Mn-induced neuroinflammation. The aim of the current study was to explore the role of NF-κB in the protective mechanism of PAS-Na on Mn-induced neuroinflammation in BV2 microglial experimental model. We treated BV2 microglia with 200 μM Mn for 24 h followed by 48 h treatment with graded concentrations of PAS-Na, using an NF-kB inhibitor, JSH-23, as a positive control. MTT results established that 200 and 400 μM PAS-Na treatment increased the Mn-induced cell viability reduction. NF-κB (P65) mRNA expression and the phosphorylation of p65 were increased in Mn-treated BV2 cell, and suppressed by PAS-Na, analogous to the effect of JSH-23 pretreatment. Furthermore, PAS-Na significantly reduced the contents of the inflammatory cytokine TNF-α and IL-1β, both of which were increased by Mn treatment. The current results show that PAS-Na attenuated Mn-induced inflammation by abrogating the activation of the NF-κB signaling pathways and reduced the release of pro-inflammatory cytokines.
- 14 January 2021
- Published by Springer Nature in Biological Trace Element Research
- Vol. 199 (12) , 4688-4699
Sodium P-aminosalicylic Acid Attenuates Manganese-Induced Neuroinflammation in BV2 Microglia by Modulating NF-κB Pathway
Exposure to high levels of manganese (Mn) leads to brain Mn accumulation, and a disease referred to as manganism. Activation of microglia plays an important role in Mn-induced neuroinflammation. Sodium p-aminosalicylic acid (PAS-Na) is a non-steroidal anti-inflammatory drug that inhibits Mn-induced neuroinflammation. The aim of the current study was to explore the role of NF-κB in the protective mechanism of PAS-Na on Mn-induced neuroinflammation in BV2 microglial experimental model. We treated BV2 microglia with 200 μM Mn for 24 h followed by 48 h treatment with graded concentrations of PAS-Na, using an NF-kB inhibitor, JSH-23, as a positive control. MTT results established that 200 and 400 μM PAS-Na treatment increased the Mn-induced cell viability reduction. NF-κB (P65) mRNA expression and the phosphorylation of p65 were increased in Mn-treated BV2 cell, and suppressed by PAS-Na, analogous to the effect of JSH-23 pretreatment. Furthermore, PAS-Na significantly reduced the contents of the inflammatory cytokine TNF-α and IL-1β, both of which were increased by Mn treatment. The current results show that PAS-Na attenuated Mn-induced inflammation by abrogating the activation of the NF-κB signaling pathways and reduced the release of pro-inflammatory cytokines.
- 6 November 2020
- Published by Springer Nature in Biological Trace Element Research
- Vol. 199 (9) , 3423-3432
Sodium P-aminosalicylic Acid Inhibits Manganese-Induced Neuroinflammation in BV2 Microglial Cells via NLRP3-CASP1 Inflammasome Pathway
Background Sodium p-aminosalicylic acid (PAS-Na) was reported to exhibit anti-inflammatory effect in the nervous system. However, the mechanism by which PAS-Na exhibits anti-inflammatory effects on manganese (Mn)-stimulated BV2 microglia cells remains unclear. Thus, this study investigated the role of PAS-Na in Mn-stimulated BV2 microglial cells. Methods Microglia-like BV2 were treated with MnCl2 with or without the non-steroidal anti-inflammatory drug PAS-Na for 12 or 24 h to examine cell viability using MTT; for 24 or 48 h to examine levels of NLRP3, CASP1, IL-1β, and IL-18 mRNA using Real-Time quantitative PCR; for 48 h to examine levels of NLRP3 and CASP1 inflammasomes, measured by western blot analysis; and for 48 h to examine levels of inflammatory cytokines, measured by enzyme-linked immunosorbent assay. Results The MTT assay showed that PAS-Na produced significant neuroprotective effect by preventing Mn-induced inflammation in BV2 microglial cells. PAS-Na significantly concentration and time dependently inhibited Mn-induced production of NLRP3, CASP1, IL-1β, and IL-18. Conclusion Taken together, our results suggest that PAS-Na exerts anti-inflammatory effects in Mn-stimulated BV2 microglial cells via downregulation of NLRP3, CASP1, IL-1β, and I L-18. Furthermore, a high concentration and prolonged PAS-Na treatment appear necessary for its therapeutic efficacy. Taken together, we conclude that PAS-Na affords therapeutic efficacy in mitigating neurological conditions associated with neuroinflammation.
- 6 November 2020
- Published by Springer Nature in Biological Trace Element Research
- Vol. 199 (9) , 3423-3432
Sodium P-aminosalicylic Acid Inhibits Manganese-Induced Neuroinflammation in BV2 Microglial Cells via NLRP3-CASP1 Inflammasome Pathway
Background Sodium p-aminosalicylic acid (PAS-Na) was reported to exhibit anti-inflammatory effect in the nervous system. However, the mechanism by which PAS-Na exhibits anti-inflammatory effects on manganese (Mn)-stimulated BV2 microglia cells remains unclear. Thus, this study investigated the role of PAS-Na in Mn-stimulated BV2 microglial cells. Methods Microglia-like BV2 were treated with MnCl2 with or without the non-steroidal anti-inflammatory drug PAS-Na for 12 or 24 h to examine cell viability using MTT; for 24 or 48 h to examine levels of NLRP3, CASP1, IL-1β, and IL-18 mRNA using Real-Time quantitative PCR; for 48 h to examine levels of NLRP3 and CASP1 inflammasomes, measured by western blot analysis; and for 48 h to examine levels of inflammatory cytokines, measured by enzyme-linked immunosorbent assay. Results The MTT assay showed that PAS-Na produced significant neuroprotective effect by preventing Mn-induced inflammation in BV2 microglial cells. PAS-Na significantly concentration and time dependently inhibited Mn-induced production of NLRP3, CASP1, IL-1β, and IL-18. Conclusion Taken together, our results suggest that PAS-Na exerts anti-inflammatory effects in Mn-stimulated BV2 microglial cells via downregulation of NLRP3, CASP1, IL-1β, and I L-18. Furthermore, a high concentration and prolonged PAS-Na treatment appear necessary for its therapeutic efficacy. Taken together, we conclude that PAS-Na affords therapeutic efficacy in mitigating neurological conditions associated with neuroinflammation.